back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-03-07 22:04 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
51 - Exercise of options
|
$-102,085
-8,500 vol $12.01 each |
0 | |
| Filed 2022-03-07 17:15 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,651 vol |
69,379 | |
| Filed 2022-03-07 17:14 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
51 - Exercise of options
|
$-102,085
-8,500 vol $12.01 each |
||
| Filed 2022-03-07 17:14 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
51 - Exercise of options
|
$-102,085
-8,500 vol $12.01 each |
0 | |
| Filed 2022-03-07 17:11 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-34,000 vol |
8,500 | |
| Filed 2022-03-07 15:09 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+62,448 vol |
62,448 | |
| Filed 2022-03-07 15:07 Tx date 2011-08-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-07 11:02 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,283,124
+106,838 vol $12.01 each |
560,395 | |
| Filed 2021-10-27 09:41 Tx date 2021-10-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,867,500
-130,000 vol $29.75 each |
65,728 | |
| Filed 2021-10-27 09:40 Tx date 2021-10-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$304,000
+95,000 vol $3.20 each |
195,728 | |
| Filed 2021-10-27 09:38 Tx date 2021-10-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-399,950
-95,000 vol $4.21 each |
453,557 | |
| Filed 2021-09-23 14:43 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-126,912.24
-5,364 vol $23.66 each |
100,728 | |
| Filed 2021-09-23 14:42 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-652,620.80
-27,136 vol $24.05 each |
106,092 | |
| Filed 2021-09-23 14:41 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,635
+11,136 vol $3.20 each |
133,228 | |
| Filed 2021-09-23 14:40 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$42,080
+16,000 vol $2.63 each |
122,092 | |
| Filed 2021-09-23 14:38 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-46,882.56
-11,136 vol $4.21 each |
548,557 | |
| Filed 2021-09-23 14:35 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-56,000
-16,000 vol $3.50 each |
559,693 | |
| Filed 2021-09-15 16:06 Tx date 2021-09-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-687,375
-32,500 vol $21.15 each |
106,092 | |
| Filed 2021-09-08 15:47 Tx date 2021-09-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-91,500
-5,000 vol $18.30 each |
138,592 | |
| Filed 2021-05-11 17:27 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$156,400
+40,000 vol $3.91 each |
143,592 | |
| Filed 2021-05-11 17:26 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-156,400
-40,000 vol $3.91 each |
575,693 | |
| Filed 2020-12-23 18:53 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,219,516
+93,593 vol $13.03 each |
615,693 | |
| Filed 2020-12-23 18:52 Tx date 2020-08-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-140,304.05
-31,529 vol $4.45 each |
522,100 | |
| Filed 2020-08-20 16:06 Tx date 2020-08-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$140,304
+31,529 vol $4.45 each |
||
| Filed 2020-10-26 14:58 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+42,500 vol |
42,500 | |
| Filed 2020-10-26 14:58 Tx date 2011-08-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-20 16:10 Tx date 2020-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-266,176.40
-14,000 vol $19.01 each |
103,592 | |
| Filed 2020-08-20 16:08 Tx date 2020-08-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$140,304
+31,529 vol $4.45 each |
117,592 | |
| Filed 2020-08-20 16:06 Tx date 2020-08-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$140,304
+31,529 vol $4.45 each |
585,158 | |
| Filed 2020-02-05 13:21 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,479,842
+61,100 vol $24.22 each |
553,629 | |
| Filed 2019-12-20 18:38 Tx date 2019-12-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,325,800
-70,000 vol $18.94 each |
86,063 | |
| Filed 2019-12-20 18:36 Tx date 2019-12-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$425,034
+100,008 vol $4.25 each |
156,063 | |
| Filed 2019-12-20 18:35 Tx date 2019-12-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,008 vol |
492,529 | |
| Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$562,799
+70,000 vol $8.04 each |
592,537 | |
| Filed 2018-06-07 Tx date 2018-05-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-1,483 vol |
0 | |
| Filed 2018-06-07 Tx date 2018-05-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$4,107
+1,483 vol $2.77 each |
56,055 | |
| Filed 2018-02-13 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,467,000
+225,000 vol $6.52 each |
522,537 | |
| Filed 2017-02-13 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$463,100
+110,000 vol $4.21 each |
297,537 | |
| Filed 2016-09-26 Tx date 2016-09-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,000 vol |
187,537 | |
| Filed 2016-09-01 Tx date 2016-08-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,000 vol |
188,537 | |
| Filed 2016-08-11 Tx date 2016-08-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,000 vol |
||
| Filed 2016-08-11 Tx date 2016-08-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,000 vol |
||
| Filed 2016-08-09 Tx date 2016-08-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,000 vol |
188,537 | |
| Filed 2016-06-23 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1,483 vol |
1,483 | |
| Filed 2016-06-23 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$9,999
+4,237 vol $2.36 each |
54,572 | |
| Filed 2016-04-01 Tx date 2016-03-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$156,400
+40,000 vol $3.91 each |
192,537 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$AUP
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$140,304
+31,529 vol $4.45 each |
152,537 | |
| Filed 2015-05-13 Tx date 2015-05-08 |
$IOT
Innovotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
40,000 |